Drugs / Cyclophosphamate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07072234 Background | Sep 2025 → Feb 2028 expected | clear cell renal carcinoma | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cyclophosphamate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07072234 ↗ |
| Route | Intravenous | “Given by IV” NCT07072234 ↗ |